We recently identified CD44, a nonkinase transmembrane glycoprotein, as a receptor that directly binds PTX3 and mediates PTX3-induced protumor effects in triple-negative breast cancer [29]. The gene discussed is PTX3; the disease is triple-negative breast carcinoma.